Brief: Hansa Biopharma Raises $71 Million Through Directed Share Issue
02/10/2025 07:34
Oct 2 (Reuters) - Hansa Biopharma AB HNSA.ST SAID ON WEDNESDAY CARRIED OUT DIRECTED SHARE ISSUE OF 17 MILLION SHARES, RAISING PROCEEDS OF ABOUT $71 MILLION SUBSCRIPTION PRICE OF SEK 39.50 PER ORDINARY SHARE Source text for Workspace: nWkr82Q4Lb Further company coverage: HNSA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS